Inventor
Alan P. Kaplan
Inventor
San Diego, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
10,053,467Therapeutic isoxazole compounds20189,956,213Substituted naphthyridine and quinoline compounds as MAO inhibitors20189,708,334'Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors'20179,675,605'Substituted naphthyridine and quinoline compounds as MAO inhibitors'20179,650,349'Therapeutic isoxazole compounds'20179,624,200'Therapeutic piperazines'20179,573,937'Substituted pyridine and pyrazine compounds as PDE4 inhibitors'20179,150,572'Substituted naphthyridine and quinoline compounds as MAO inhibitors'20159,120,770'Substituted pyridine and pyrazine compounds as PDE4 inhibitors'20159,102,674'Substituted naphthyridine and quinoline compounds as MAO inhibitors'20159,040,692'Substituted pyridine and pyrazine compounds as PDE4 inhibitors'20159,029,397'Therapeutic isoxazole compounds'20159,012,470'Therapeutic 5,6,5-tricyclic analogs'20158,927,546'Therapeutic piperazines'20158,921,399'Therapeutic isoxazole compounds'20148,791,137'Therapeutic compounds'20148,598,159'Therapeutic pyrazoloquinoline derivatives'20138,501,745'Piperazine PDE4 inhibitors and uses thereof'20138,497,262'Therapeutic pyrazolonaphthyridine derivatives'20138,399,487'Pyrazole compounds and uses thereof'20138,343,957'Therapeutic pyrazoloquinoline urea derivatives'20138,338,405'Therapeutic piperazines'20128,277,842'Enteric-coated HT-2157 compositions and methods of their use'20128,222,243'Therapeutic isoxazole compounds'20127,919,626'Pyrazole compounds and uses thereof'20117,872,002'Therapeutic pyrazoloquinoline derivatives'20117,863,266'Therapeutic pyrazoloquinoline urea derivatives'20117,858,614'Therapeutic pyrazolonaphthyridine derivatives'20107,829,713'Therapeutic piperazines'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2011Patents assigned to HELICON THERAPEUTICS INC (5)· patent assignee history
2010–2018Based in San Diego, CA, US· patent location history
2010–2014Based in Kings Park, CA, US· patent location history
2012–2018Patents assigned to DART NEUROSCIENCE CAYMAN LTD (18)· patent assignee history
2012–2015Patents assigned to KAPLAN ALAN P (13)· patent assignee history
2012–2015Patents assigned to KEENAN TERENCE P (8)· patent assignee history
2017Patents assigned to DART NEUROSCIENCE (CAYMAN) LTD (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DART NEUROSCIENCE CAYMAN LTD | 18 | 2012–2018 |
| KAPLAN ALAN Pself | 13 | 2012–2015 |
| KEENAN TERENCE P | 8 | 2012–2015 |
| DART NEUROSCIENCE (CAYMAN) LTD | 5 | 2017 |
| HELICON THERAPEUTICS INC | 5 | 2010–2011 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 24 | 2010–2018 |
| Kings Park, California, US | 5 | 2010–2014 |